| Study | Setting | Total participants | Participants with HF | Country | Average age at outset, years | 1-year survival, % | 2-year survival, % | 5-year survival, % | 10-year survival, % |
|---|---|---|---|---|---|---|---|---|---|
| Mosterd et al 20015 | Participants from Rotterdam population study screened for diagnosis or symptoms of HF | 5255 | 181 | The Nether-lands | 68.9 | 89 | 79 | 59 | – |
| Nielsen et al 20036 | Cross-sectional sample from three general practices, screened for participants with diagnosis or symptoms of HF | 2157 including control group (571) and heart disease but no HF (218) | 67 with community managed HF: 33 in hospital managed HF comparator | Denmark | 74.1 | – | – | 61 | – |
| Hobbs et al 20077 | Participants from UK general practice screened for HF | 6162 including 1062 at high risk for HF and 982 on diuretics at baseline | Previous clinical label of HF ( 782) | UK | 64.2 | – | – | 63 | – |
| Tsutsui et al 20078 | Data from The Cardiac Registry of Heart Failure in General Practice | 2685 | 1280 followed-up in hospital and 1405 by GP | Japan | 74 | 90.9 | – | – | – |
| Pons et al 20109 | Consecutive sample from outpatient HF clinic | 960 | All followed-up in outpatient cardiology clinic | Spain | 69 | 89.4 | – | – | – |
| Taylor et al 201210 | As per Hobbs et al 2007 paper:7 10-year follow-up of ECHOES cohort | See above | See above | UK | 64.2 | – | – | – | 26.7 |
| Taylor et al 201711 | Survival analysis using UK primary care records from The Health Improvement Network | 54 313 | All with first diagnosis of HF | UK | 76.5 | 81.3 | – | 51.5 | 29.5 |
ECHOES = Echocardiographic Heart of England Screening (ECHOES). HF = heart failure.